2008
DOI: 10.2147/tcrm.s140
|View full text |Cite
|
Sign up to set email alerts
|

Serotonin receptor modulators in the treatment of irritable bowel syndrome

Abstract: Abstract:The aim of this article is to review the pathophysiology and clinical role of serotonin receptor modulators used in the treatment of irritable bowel syndrome. Serotonin is an important monoamine neurotransmitter that plays a key role in the initiation of peristaltic and secretory refl exes, and in modulation of visceral sensations. Several serotonin receptor subtypes have been characterized, of which 5HT3, 5HT4, and 5HT1b are the most important for GI function. 5HT4 agonists (eg, tegaserod) potentiate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(9 citation statements)
references
References 77 publications
0
9
0
Order By: Relevance
“…It was notable that three individuals reported here with MMIHS due to apparent de novo mutations in ACTG2 reported clinical improvement on cisapride, a serotonergic 5HT 4 agonist. Serotonergic activity at the 5HT 4 receptor has been noted to be a therapeutic target for constipation and irritable bowel syndrome [38] . Cisapride was proposed as a therapy for MMIHS in 1991 [14] .…”
Section: Discussionmentioning
confidence: 99%
“…It was notable that three individuals reported here with MMIHS due to apparent de novo mutations in ACTG2 reported clinical improvement on cisapride, a serotonergic 5HT 4 agonist. Serotonergic activity at the 5HT 4 receptor has been noted to be a therapeutic target for constipation and irritable bowel syndrome [38] . Cisapride was proposed as a therapy for MMIHS in 1991 [14] .…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, about 95% of the serotonin in the body is found in the GI tract. Colonic distention results in the secretion of serotonin by enterochromaffin cells, which will induce nausea and vomiting [12]. For this reason, we propose the use of 5 HT-3 receptor antagonists for the prevention of vomiting due to colonic distention, especially for patients with risk factors for postoperative nausea and vomiting [13].…”
Section: Discussionmentioning
confidence: 99%
“…Patients diagnosed with IBS or other bowel diseases show high levels of 5-HT and an increased frequency of T H17 cells. In fact, both 5-HTR agonists and antagonists have been used to treat IBS that also helped with other related symptoms ( 213 ). 5-HT 3 , 5-HT 4 , and 5HT 1B are the most important receptors for GI function.…”
Section: Immunomodulatory Neurotransmittersmentioning
confidence: 99%